Literature DB >> 33799934

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature.

Melissa Krizia Vieri1, An Hotterbeekx1,2, Stephen Raimon3, Gasim Abd-Elfarag4,5, Deby Mukendi6,7, Jane Y Carter8, Samir Kumar-Singh2, Robert Colebunders1.   

Abstract

Neuro-inflammation may be associated with onchocerciasis-associated epilepsy (OAE) but thus far very few immunological studies have been performed in children with this form of epilepsy. In a pilot study we measured the cytokine levels in cerebrospinal fluid (CSF) of persons with OAE from Maridi, South Sudan, and from Mosango, Democratic Republic of the Congo (DRC) and compared these results with cytokine levels in CSF of Africans with non-OAE neurological disorders, and Europeans with epilepsy or other neurological conditions. The following cytokines were studied: IL-6, TNF-α, IL1-β, IL-5, IL-4, IL-13, CCL3 (Mip-1α), VEGF-C, VCAM-1. No cytokine was significantly associated with OAE, although a lower IL-13 level was observed in CSF of persons with OAE compared to African controls. Observed cytokine profiles and neuro-inflammation may be the consequence of long-standing epilepsy, concomitant infections and malnutrition. Ideally cytokine levels should be determined in a prospective study in serum and CSF collected at the time of onset of the first seizures.

Entities:  

Keywords:  cerebrospinal fluid; cytokines; onchocerciasis-associated epilepsy

Year:  2021        PMID: 33799934      PMCID: PMC7998365          DOI: 10.3390/pathogens10030310

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  26 in total

1.  Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine.

Authors:  B O Duke; J Vincelette; P J Moore
Journal:  Tropenmed Parasitol       Date:  1976-06

Review 2.  The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections.

Authors:  F D Finkelman; T A Wynn; D D Donaldson; J F Urban
Journal:  Curr Opin Immunol       Date:  1999-08       Impact factor: 7.486

Review 3.  Inflammatory mediators in human epilepsy: A systematic review and meta-analysis.

Authors:  Evelien E de Vries; Bart van den Munckhof; Kees P J Braun; Annet van Royen-Kerkhof; Wilco de Jager; Floor E Jansen
Journal:  Neurosci Biobehav Rev       Date:  2016-02-11       Impact factor: 8.989

4.  Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.

Authors:  C S Mai; D M Hamm; M Banla; A Agossou; H Schulz-Key; C Heuschkel; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

5.  Onchocerca volvulus microfilariae avoid complement attack by direct binding of factor H.

Authors:  Taru Meri; T Sakari Jokiranta; Jens Hellwage; Alexandra Bialonski; Peter F Zipfel; Seppo Meri
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

6.  HMGB-1, TLR4, IL-1R1, TNF-α, and IL-1β: novel epilepsy markers?

Authors:  Tülay Kamaşak; Beril Dilber; Serap Özer Yaman; Betül Diler Durgut; Tuba Kurt; Elif Çoban; Elif Acar Arslan; Sevim Şahin; Süleyman Caner Karahan; Ali Cansu
Journal:  Epileptic Disord       Date:  2020-04-01       Impact factor: 1.819

7.  A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy.

Authors:  Cédric B Chesnais; Charlotte Bizet; Jérémy T Campillo; Wepnyu Y Njamnshi; Jean Bopda; Philippe Nwane; Sébastien D Pion; Alfred K Njamnshi; Michel Boussinesq
Journal:  Open Forum Infect Dis       Date:  2020-06-02       Impact factor: 3.835

8.  High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.

Authors:  Deby Mukendi; Floribert Tepage; Innocent Akonda; Joseph Nelson Fodjo Siewe; Anke Rotsaert; Carl Nwana Ndibmun; Anne Laudisoit; Simon Couvreur; Blandine Kabutako; Sonia Menon; An Hotterbeekx; Robert Colebunders
Journal:  Int J Infect Dis       Date:  2019-02       Impact factor: 3.623

9.  Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers.

Authors:  Zuzana Liba; Hana Nohejlova; Vaclav Capek; Pavel Krsek; Anna Sediva; Jana Kayserova
Journal:  PLoS One       Date:  2019-07-29       Impact factor: 3.240

10.  Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy.

Authors:  An Hotterbeekx; Stephen Raimon; Gasim Abd-Elfarag; Jane Y Carter; Wilson Sebit; Abozer Suliman; Joseph Nelson Siewe Fodjo; Peter De Witte; Makoy Yibi Logora; Robert Colebunders; Samir Kumar-Singh
Journal:  Int J Infect Dis       Date:  2019-11-29       Impact factor: 3.623

View more
  1 in total

Review 1.  Nodding Syndrome: A Scoping Review.

Authors:  Gasim Omer Elkhalifa Abd-Elfarag; Arthur Wouter Dante Edridge; René Spijker; Mohamed Boy Sebit; Michaël B van Hensbroek
Journal:  Trop Med Infect Dis       Date:  2021-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.